newsfilter
← Latest News
GlobeNewswire·

Statera Biopharma Announces Preliminary Revenue and Financial Results of Fiscal Year '21

FORT COLLINS, Colo., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (NASDAQ:STAB) (the "Company" or "Statera Biopharma"), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and home